Unique and potent effects of acute ibogaine on zebrafish: The developing utility of novel aquatic models for hallucinogenic drug research
Mechanisms Preclinical moderate
AI-extracted · unverified · confirm at source
Zebrafish ibogaine exposure (10–20 mg/L) reverses geotaxis and scototaxis, disrupts shoaling, evokes melanophore darkening, and validates aquatic 3D phenotyping for hallucinogen research.
Dosing: 10–20 mg/L aquatic immersion (20 min pre-treatment)